Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Non-Current Debt (2019 - 2025)

Historic Non-Current Debt for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $148.5 million.

  • Harmony Biosciences Holdings' Non-Current Debt fell 1152.3% to $148.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $148.5 million, marking a year-over-year decrease of 1152.3%. This contributed to the annual value of $163.0 million for FY2024, which is 870.83% down from last year.
  • Harmony Biosciences Holdings' Non-Current Debt amounted to $148.5 million in Q3 2025, which was down 1152.3% from $153.3 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Non-Current Debt's 5-year high stood at $195.6 million during Q2 2021, with a 5-year trough of $148.5 million in Q3 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' median Non-Current Debt value was $182.1 million (recorded in 2023), while the average stood at $178.6 million.
  • In the last 5 years, Harmony Biosciences Holdings' Non-Current Debt dropped by 17.74% in 2022 and then crashed by 1152.3% in 2025.
  • Harmony Biosciences Holdings' Non-Current Debt (Quarter) stood at $190.0 million in 2021, then fell by 0.18% to $189.6 million in 2022, then decreased by 5.84% to $178.6 million in 2023, then fell by 8.71% to $163.0 million in 2024, then decreased by 8.9% to $148.5 million in 2025.
  • Its Non-Current Debt stands at $148.5 million for Q3 2025, versus $153.3 million for Q2 2025 and $158.2 million for Q1 2025.